A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
This study is conducted in Japan. The aim of the study is to evaluate the efficacy of
 somatropin (Norditropin®) on adult height (cm) in patients with achondroplasia /
 hypochondroplasia enrolled in the GH-1941 study (NCT01516229).
Inclusion Criteria:

 -  Patients who were enrolled in the GH-1941 study (1997 to 2006) and expected to
 theoretically reach the adult height within the study period